Literature DB >> 29359766

A lipid-based cell penetrating nano-assembly for RNAi-mediated anti-angiogenic cancer therapy.

Poulami Majumder1, Sukanya Bhunia, Arabinda Chaudhuri.   

Abstract

Limited tumor tissue penetration is one of the key impeding factors retarding successful in vivo exploitations of anti-angiogenic cancer therapy. Herein we report on the design of a cell penetrating peptide-decorated lipid nano-assembly which, upon systemic administration, induces significant mouse tumor growth inhibition via enhanced tumor infiltration of encapsulated anti-angiogenic siRNA.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29359766     DOI： 10.1039/c7cc08517f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  9 in total

1.  Charge-Conversion Strategies for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; Pintu Kanjilal; S Thayumanavan
Journal:  Adv Funct Mater       Date:  2021-03-31       Impact factor: 19.924

2.  Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems.

Authors:  Anna-Laurence Schachner-Nedherer; Oliver Werzer; Karin Kornmueller; Ruth Prassl; Andreas Zimmer
Journal:  Int J Nanomedicine       Date:  2019-09-25

3.  Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; S Thayumanavan
Journal:  Biochemistry       Date:  2021-01-11       Impact factor: 3.162

Review 4.  Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment.

Authors:  Deidra M Ward; Aaliyah B Shodeinde; Nicholas A Peppas
Journal:  Adv Healthc Mater       Date:  2021-05-11       Impact factor: 11.092

5.  Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.

Authors:  Cuiling Zhang; Weigang Ren; Qingxin Liu; Zhikai Tan; Junwei Li; Chunyi Tong
Journal:  Drug Des Devel Ther       Date:  2019-04-04       Impact factor: 4.162

6.  Fabrication of KR-12 peptide-containing hyaluronic acid immobilized fibrous eggshell membrane effectively kills multi-drug-resistant bacteria, promotes angiogenesis and accelerates re-epithelialization.

Authors:  Menglong Liu; Tengfei Liu; Xiaorong Zhang; Zhiwen Jian; Hesheng Xia; Jiacai Yang; Xiaohong Hu; Malcolm Xing; Gaoxing Luo; Jun Wu
Journal:  Int J Nanomedicine       Date:  2019-05-07

7.  Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.

Authors:  Wenhua Zhang; Wenhua Xu; Yu Lan; Xuliang He; Kaibin Liu; Ye Liang
Journal:  Int J Nanomedicine       Date:  2019-07-15

8.  Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.

Authors:  Dereje Kebebe; Yumei Wu; Bing Zhang; Jian Yang; Yuanyuan Liu; Xinyue Li; Zhe Ma; Peng Lu; Zhidong Liu; Jiawei Li
Journal:  Int J Nanomedicine       Date:  2019-08-02

9.  Delivery of antisense oligonucleotide using polyethylenimine-based lipid nanoparticle modified with cell penetrating peptide.

Authors:  Shuang Yang; Dandan Wang; Yaojun Sun; Bin Zheng
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.